Investment Visual

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Revenue, 2025: €720M
YoY, 2025: +98.0%
5-year CAGR: +153.0%
10-year CAGR: +56.6%

Revenue

Revenue by fiscal year

Period	Ended	Revenue	YoY	Filing
2025	Dec 31, 2025	€720M	+98.0%	20-F, Feb 11, 2026
2024	Dec 31, 2024	€364M	+36.3%	20-F, Feb 12, 2025
2023	Dec 31, 2023	€267M	+421.2%	20-F, Feb 7, 2024
2022	Dec 31, 2022	€51M	+557.9%	20-F, Feb 16, 2023
2021	Dec 31, 2021	€7.8M	+11.9%	20-F, Mar 2, 2022
2020	Dec 31, 2020	€7.0M	−48.0%	20-F, Mar 10, 2021
2019	Dec 31, 2019	€13M	+26.4%	20-F, Apr 3, 2020
2018	Dec 31, 2018	€11M	+591.6%	20-F, Apr 3, 2019
2017	Dec 31, 2017	€1.5M	−66.8%	20-F, Mar 28, 2018
2016	Dec 31, 2016	€4.6M	−43.3%	20-F, Mar 28, 2018
2015	Dec 31, 2015	€8.1M	—	20-F, Mar 28, 2018